Dulox
Generic Name
Duloxetine
Manufacturer
Square Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
Variant | Unit Price | Strip Price |
---|---|---|
dulox 30 mg tablet | ৳ 12.00 | ৳ 120.00 |
Description
Overview of the medicine
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, chronic musculoskeletal pain, and fibromyalgia.
Uses & Indications
Dosage
Adults
Major Depressive Disorder/Generalized Anxiety Disorder: Initial dose 30 mg once daily for 1 week, then 60 mg once daily. Max 120 mg/day. Diabetic Peripheral Neuropathic Pain/Chronic Musculoskeletal Pain/Fibromyalgia: 60 mg once daily.
Elderly
No specific dose adjustment for elderly, but caution advised. Initiate at lower dose and monitor closely.
Renal_impairment
Avoid in severe renal impairment (creatinine clearance <30 mL/min). For moderate impairment, dose adjustment may be necessary. Consult physician.
How to Take
Take orally once daily, with or without food. Swallow the tablet whole; do not crush, chew, or open. Consistency in taking at the same time each day is recommended.
Mechanism of Action
Duloxetine works by increasing the levels of serotonin and norepinephrine, two natural substances in the brain that help maintain mental balance and stop the movement of pain signals in the body.
Pharmacokinetics
Onset
Antidepressant effects typically begin within 2-4 weeks. Pain relief may be observed sooner.
Excretion
Primarily excreted in urine (about 70%) and feces (about 20%) as metabolites.
Half life
Approximately 12 hours (range 8-17 hours).
Absorption
Well absorbed after oral administration, though food can decrease Cmax and delay Tmax. Bioavailability is about 50%.
Metabolism
Extensively metabolized in the liver by CYP1A2 and CYP2D6 to inactive metabolites.
Side Effects
Contraindications
- Hypersensitivity to duloxetine or any component of the formulation
- Concomitant use with MAOIs (Monoamine Oxidase Inhibitors) or within 14 days of discontinuing an MAOI
- Uncontrolled narrow-angle glaucoma
- Severe renal impairment (CrCl <30 mL/min)
- Severe hepatic impairment or end-stage renal disease
Drug Interactions
MAOIs
Concomitant use is contraindicated due to increased risk of serotonin syndrome.
SSRIs and other SNRIs
Increased risk of serotonin syndrome.
Warfarin and other anticoagulants
Increased risk of bleeding due to duloxetine's effect on platelet aggregation.
CYP1A2 Inhibitors (e.g., fluvoxamine, ciprofloxacin)
May significantly increase duloxetine levels.
CYP2D6 Substrates (e.g., tricyclic antidepressants, risperidone, thioridazine)
Duloxetine is a moderate inhibitor of CYP2D6, potentially increasing concentrations of co-administered drugs metabolized by CYP2D6.
Storage
Store at room temperature (below 30°C), in a dry place, protected from light and moisture. Keep out of reach of children.
Overdose
Symptoms of overdose include somnolence, coma, serotonin syndrome, seizures, vomiting, and tachycardia. Management is primarily supportive; maintain an open airway, monitor cardiac and vital signs, and provide symptomatic and supportive care. Activated charcoal may be considered.
Pregnancy & Lactation
Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in human milk; caution should be exercised when administered to a nursing woman. Consult your doctor.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
Typically 24-36 months from the date of manufacture, depending on the manufacturer.
Availability
Pharmacies and hospitals
Approval Status
Approved by FDA and DGDA
Patent Status
Generic available
Clinical Trials
Numerous clinical trials have established duloxetine's efficacy and safety across its approved indications, including major depressive disorder, generalized anxiety disorder, and various neuropathic and chronic pain conditions.
Lab Monitoring
- Liver function tests (baseline and periodically)
- Blood pressure (regularly)
- Renal function (for patients with renal impairment)
Doctor Notes
- Regularly monitor blood pressure, especially in patients with pre-existing hypertension.
- Assess for suicidal ideation, particularly in pediatric, adolescent, and young adult patients at treatment initiation or dose changes.
- Caution is advised in patients with a history of seizures, bipolar disorder (mania/hypomania), or severe gastrointestinal motility disorders.
- Liver function tests should be monitored periodically.
Patient Guidelines
- Do not stop duloxetine abruptly to avoid withdrawal symptoms; dosage should be gradually reduced under medical supervision.
- Report any worsening of depression, suicidal thoughts, or unusual changes in behavior to your doctor immediately.
- Avoid alcohol consumption while taking this medicine.
- Be aware of symptoms of serotonin syndrome (e.g., agitation, hallucinations, rapid heart rate, fever).
Missed Dose Advice
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double dose to catch up.
Driving Precautions
Duloxetine may cause dizziness, drowsiness, or blurred vision. Patients should be cautious when driving or operating hazardous machinery until they know how the medicine affects them.
Lifestyle Advice
- Maintain a healthy and balanced diet.
- Engage in regular physical activity as tolerated.
- Practice stress-reduction techniques such as meditation or yoga.
- Ensure adequate sleep and maintain a consistent sleep schedule.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
Related
Medicines
Explore similar medicines to find the best option for your healthcare needs.
EuroORS
Euro Pharma Ltd.
Avloquin-H
General Pharmaceuticals Ltd.
Axovit
Reputable Pharma Ltd.
Expreso Plus
Pharma Beximco
Evoloxin
Incepta Pharmaceuticals Ltd.
Exler
Incepta Pharmaceuticals
Exomi MUPS
Square Pharmaceuticals Ltd.
Exipain
Acme Laboratories Ltd.
Azi S
Square Pharmaceuticals Ltd.
Axxo
Square Pharmaceuticals Ltd.